IRIS
OSELLA, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.030
EU - Europa 11.113
AS - Asia 5.712
SA - Sud America 911
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 176
OC - Oceania 5
Totale 30.193
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.797
RU - Federazione Russa 2.632
IE - Irlanda 2.354
SG - Singapore 1.749
SE - Svezia 1.689
CN - Cina 1.570
DE - Germania 1.471
UA - Ucraina 1.109
HK - Hong Kong 904
VN - Vietnam 739
BR - Brasile 693
FI - Finlandia 657
IT - Italia 399
FR - Francia 372
GB - Regno Unito 221
IN - India 213
CA - Canada 135
KR - Corea 113
AR - Argentina 87
BD - Bangladesh 81
MX - Messico 60
BJ - Benin 52
ID - Indonesia 49
PL - Polonia 46
IR - Iran 42
TR - Turchia 39
ZA - Sudafrica 39
EC - Ecuador 35
JP - Giappone 35
BE - Belgio 34
IQ - Iraq 27
ES - Italia 26
CO - Colombia 25
EU - Europa 23
UZ - Uzbekistan 23
NL - Olanda 22
AT - Austria 19
CL - Cile 18
PY - Paraguay 18
MA - Marocco 17
PK - Pakistan 16
TH - Thailandia 15
LT - Lituania 14
SA - Arabia Saudita 14
VE - Venezuela 13
EG - Egitto 12
PH - Filippine 12
RO - Romania 12
KE - Kenya 11
TN - Tunisia 11
DZ - Algeria 9
BO - Bolivia 8
JM - Giamaica 8
NP - Nepal 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
CR - Costa Rica 7
JO - Giordania 7
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
TW - Taiwan 6
AU - Australia 5
AZ - Azerbaigian 5
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
PA - Panama 4
PE - Perù 4
PR - Porto Rico 4
PS - Palestinian Territory 4
CI - Costa d'Avorio 3
GR - Grecia 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
QA - Qatar 3
SV - El Salvador 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CZ - Repubblica Ceca 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
Totale 29.953
Salva come PNG Salva come JPEG
Città #
Dublin 2.347
Jacksonville 1.887
Dearborn 984
Hong Kong 896
San Jose 894
Chandler 805
Singapore 755
Ashburn 640
Council Bluffs 608
Wilmington 572
Beijing 509
Moscow 402
Lawrence 319
Princeton 319
Lauterbourg 289
Ann Arbor 256
San Mateo 253
Ho Chi Minh City 244
Los Angeles 241
New York 238
Andover 202
Buffalo 159
Hanoi 155
Columbus 143
Piemonte 133
Seoul 108
Munich 102
Boardman 101
Houston 99
Woodbridge 93
Philadelphia 90
Düsseldorf 89
Santa Clara 83
São Paulo 77
Orem 71
Toronto 71
Dallas 70
Redondo Beach 59
Bremen 58
Guangzhou 53
Cotonou 52
Grafing 49
Hefei 47
Nanjing 47
Helsinki 46
Atlanta 45
Chicago 41
Norwalk 41
Frankfurt am Main 40
Kunming 36
Tianjin 34
Chennai 33
Da Nang 33
Brussels 32
Tokyo 31
Warsaw 31
Monmouth Junction 28
Denver 27
Leawood 27
Montreal 27
Brooklyn 26
Shanghai 26
Stockholm 26
Hangzhou 24
Mexico City 24
Rio de Janeiro 24
Haiphong 23
Phoenix 22
Biên Hòa 21
Fairfield 21
London 21
Tashkent 21
Novara 20
Manchester 19
Mumbai 19
Poplar 19
Shenzhen 19
Zanjan 19
Belo Horizonte 18
San Francisco 18
Nuremberg 17
Ankara 16
Boston 16
Cave Creek 16
Jinan 16
Johannesburg 16
Turku 16
Hải Dương 15
Seattle 15
Hebei 14
Ardabil 13
Bexley 13
Shenyang 13
Amsterdam 12
Augusta 12
Curitiba 12
Porto Alegre 12
Quito 12
Zhengzhou 12
Brasília 11
Totale 16.930
Salva come PNG Salva come JPEG
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 169
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 161
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 154
A view on multi-action Pt(IV) antitumor prodrugs 154
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 152
195Pt NMR chemical shift: a chemometric approach 149
Transition metal carbonyl clusters in biology: A futile or niche research area? 147
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 146
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 144
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 143
Antioxidant Composition of a Selection of Italian Red Wines and Their Corresponding Free-Radical Scavenging Ability 143
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 142
A different way for the oxidation of the Pt(II) complexes 141
Haemolymph from Mytilus galloprovincialis: Response to copper and temperature challenges studied by 1H-NMR metabonomics 141
13C Solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12] 141
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 141
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 141
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 140
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 139
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 139
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 138
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 136
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 136
Different strategies to exploit Pt(IV) complexes as pro-drugs 135
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 134
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 134
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 133
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 133
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 133
1H-NMR SPIN-LATTICE RELAXATION STUDIES OF HYDRIDOMETAL CLUSTERS OF RUTHENIUM AND OSMIUM 132
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 132
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 131
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process. 129
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 129
ACTIVATION OF THE M-CO BOND IN TRANSITION-METAL COMPLEXES. FE2(CO)6(SME)2 AND PHOSPHINE-SUBSTITUTED DERIVATIVES AS GOOD CATALYSTS IN METAL-CARBONYL SUBSTITUTION-REACTIONS 129
199Hg NMR of mercury-bridged transition metal clusters 129
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 128
Activation of alkynes by transition metals 126
17O NMR spectroscopy of transition metal carbonyls 126
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 125
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 125
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 124
An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2 123
Effect of arbuscular mycorrhizal and bacterial inocula on nitrate concentration in mesocosms simulating a wastewater treatment system relying on phytodepuration 123
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 122
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 120
A novel bonding scheme of an allene system in a transition metal cluster complex. Molecular structure of μ3-η-(1-methyl-3-ethyl-3-allenyl)-μ-hydrido-triangulo- tris(tricarbonylruthenium)(3Ru-Ru) 119
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 119
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 119
Authentication and traceability study of Hazelnuts from piedmont, italy 118
Wine Traceability with Rare Earth Elements 118
A MECHANISTIC STUDY OF THE REACTION OF H2OS3(CO)10 WITH TERMINAL ALKYNES 117
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 117
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 117
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 117
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 117
Pt-195 NMR spectroscopy: A chemometric approach 116
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 115
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process 114
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 114
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 113
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 113
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 113
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 112
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 112
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 112
A 13C NMR investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium 112
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 111
13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants 111
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 110
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 110
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 110
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 110
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 109
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 109
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 109
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 108
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 108
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 108
Solution structure and dynamics of H2Ru4(CO)13 107
Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls 105
μ3-S bonding mode in H2M3(CO)9S clusters of Ru and Os. An UV-PES and theoretical study 105
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 105
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 104
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer 104
Pt(IV) complexes as anticancer prodrugs 104
13C-13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt 104
The effects of sulphur dioxide on wine metabolites: New insights from 1H NMR spectroscopy based in-situ screening, detection, identification and quantification 104
THE ALKYNE CLUSTER INTERACTION - STRUCTURAL, THEORETICAL, AND SPECTROSCOPIC STUDY ON THE PARALLEL μ3-η2 BONDING MODE IN TRINUCLEAR CARBONYL CLUSTERS OF RUTHENIUM AND OSMIUM 103
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 103
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 103
THERMAL AND PHOTOCHEMICAL BEHAVIOR OF ORGANOTETRARUTHENIUM CLUSTERS: SOLUTION STRUCTURES AND DYNAMICS OF PHOSPHINE-SUBSTITUTED DERIVATIVES 103
The structures and fluxional behaviour of the binary carbonyls; A new approach. Part 3. The fluxional behaviour of [Fe3(CO)11L], L = PR3 or P(OR)3 103
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 103
High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12 102
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 102
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 102
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 102
Wine evolution during bottle aging, studied by 1H NMR spectroscopy and multivariate statistical analysis 102
Unsymmetric cisplatin-based pt(Iv) conjugates containing a parp-1 inhibitor pharmacophore tested on malignant pleural mesothelioma cell lines 102
Totale 12.201
Salva come PNG Salva come JPEG
Categoria #
all - tutte 153.082
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.082
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.367 0 29 585 363 117 1 257 43 139 35 347 451
2022/20235.085 338 133 303 231 418 590 81 277 2.426 39 161 88
2023/20241.162 120 103 102 25 269 1 244 10 4 6 126 152
2024/20252.605 24 44 105 101 106 186 244 187 809 343 85 371
2025/202610.045 411 379 806 1.414 781 790 1.539 1.755 794 691 425 260
2026/20271.020 410 610 0 0 0 0 0 0 0 0 0 0
Totale 30.193